Intermittent treatment of BAY1082439 on castrated mice inoculated with PTEN-null PCa cells was found to promote the expansion of CD8+ T cells and sensitize the PTEN-negative PCa xenografts to the anti-PD-1 immunotherapy (Table 1) [44]. The gene discussed is CD8A; the disease is posterior cortical atrophy.